Table 2.
Success rate regarding EDGE technique and its variants (GATE and EDGI).
| First Name, Year | Article Type | N. of Patient | Type of Surgery | Endoscopic Technique | LAMS Diameter | Technical Success | Clinical Success | E-AEs Reported |
|---|---|---|---|---|---|---|---|---|
| Kedia [62], 2015 | Prospective study | 5 | RYGB | SS–EDGE 3 DS-EGDE 2 |
15 mm | 100% | 60% | stent dislodgement: 60% |
| Tyberg [63], 2016 | Prospective study | 16 | RYGB | SS–EDGE 4 DS-EGDE 6 |
15 mm | 100% | 91% | Stent migration(19%), 1 jejunal perforation |
| Ngamruengphong [64], 2017 | Retrospective study | 13 | RYGB | SS–EDGE 2 DS-EGDE 11 |
15 mm | 100% | 100% | Stent migration(33%) |
| James and Baron [65], 2018 | Retrospective Study | 19 | RYGB | SS–EDGE 4 DS-EGDE 15 |
15 mm | 100% | 100% | Stent malposition(6/19) |
| Bukhari [66], 2018 | Retrospective Study | 30 | RYGB | SS–EDGE 8 DS-EGDE 22 |
15 mm | 100% | 100% | LAMS migration(6.7%),bleeding(3.3%) |
| Chiang [67], 2018 | Oral Abstract–retrospective study | 66 | RYGB | SS–EDGE 43 DS-EGDE 23 |
NR | 92.4% | NR | Bleeding (7.6%), LAMS malposition(4.5%), LAMS migration (4.5%), perforation (1.5%), pancreatitis(1.5%) |
| Kedia [68], 2018 | Retrospective study | 29 | RYGB | NR | 15 mm | 96.5% | 96.5% | Perforation (1),pancreatitis (2)stentdislodgement(3)bleeding (1). |
| Wang [73], 2019 | Retrospective study | 10 | RYGB | SS–GATE 7 DS-GATE 2 |
15 mm | 100% | 100% | Stent migration (20%), bleeding in one patient |
| Hsueh [69], 2019 | Oral Abstract –Retrospective study | 9 | RYGB | SS–EDGE 2 DS-EGDE 7 |
20 mm | 100% | 100% | None |
| Runge [70], 2020 | Retrospective study | 178 | RYGB | SS –EDGE 85 DS-EGDE 81 |
NR | 98% | NR | Perforation(6), stentmigration(13),bleeding (2), Pneumoperitoneum(3),post ERCP pancreatitis(3), cholangitis (1) |
| Krafft [74], 2019 | Retrospective study | 14 | RYGB | SS –EDGI 5 DS-EGDI 2 |
20 mm (n =8) 15 mm(n =6) |
100% | 100% | Stentdislodgement(14.3%) |
| Khara [72], 2021 | Retrospective study | 76 | RYGB | 59 LA-ERCP 17 EDGE |
20 mm | Both 100% | Both 100% | 17% LA-ERCP 6% EDGE |
EDGE= EUS-directed transgastric ERCP; E-Aes= Endoscopy-related adverse events. EDGI= EUS-directed transgastric intervention; GATE= Gastric Access temporary for Endoscopy; SS= single stage; DS= double stage; GGF= gastrogastric fistula; LA-ERCP= Laparoscopic–ERCP.